Characterization of the effect of AG337, a novel lipophilic thymidylate synthase inhibitor, on human head and neck and human leukemia cell lines.

International journal of oncology

Volumn 15, Issue 6, 1999, Pages 1245-1250

  McGuire, J J ^a   Canestrari, J G ^a   Nagel, G S ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; FOLINIC ACID; HYPOXANTHINE; METHOTREXATE; NOLATREXED; QUINAZOLINE DERIVATIVE; THYMIDINE; THYMIDINE PHOSPHORYLASE; THYMIDYLATE SYNTHASE;

ARTICLE; CELL CULTURE; CELL CYCLE; CELL DIVISION; CHEMISTRY; COMPARATIVE STUDY; CULTURE MEDIUM; DRUG ANTAGONISM; DRUG EFFECT; DRUG RESISTANCE; FETUS BLOOD; HEAD AND NECK TUMOR; HUMAN; IC 50; LEUKEMIA; METABOLISM; PATHOLOGY;

CELL CYCLE; CELL DIVISION; CULTURE MEDIA; DRUG RESISTANCE; ENZYME INHIBITORS; FETAL BLOOD; HEAD AND NECK NEOPLASMS; HUMANS; HYPOXANTHINE; INHIBITORY CONCENTRATION 50; LEUCOVORIN; LEUKEMIA; METHOTREXATE; QUINAZOLINES; THYMIDINE; THYMIDINE PHOSPHORYLASE; THYMIDYLATE SYNTHASE; TUMOR CELLS, CULTURED;

EID: 0033451247     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.15.6.1245     Document Type: Article

References (0)